Skip to content

Allotment

Q-Line Biotech Limited

Q-Line Biotech IPO open date is 2026 and the IPO will close on 2026. Q-Line Biotech IPO is a Book build Issue. The company plans to raise around ₹[.] crores through the IPO, which consists of a fresh issue of ₹[.] crores and an offer for sale of up to [.] equity shares with a face value of ₹10 each.

Q-Line Biotech IPO price band is ₹[.] to ₹[.] per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Q-Line Biotech IPO is proposed to list on NSE in 2026, while the allotment date for the IPO is also scheduled in 2026.

The company reported revenue of ₹322.58 crores in 2025 compared to ₹206.45 crores in 2024. It posted a profit of ₹28.13 crores in 2025 against a profit of ₹34.44 crores in 2024. Based on the financial performance, long-term investors may consider applying for the IPO.

Q-Line Biotech Limited IPO & Charts
₹343

0%

Open

₹343

HIgh - Low

₹343

Previous Close

₹343

Total Traded Value

0

52 Weeks High

₹343

52 Weeks Low

₹343

Updates On

May 15, 2025

IPO. Open

May 21, 2026

IPO. Close

May 25, 2026

IPO. Price

₹343.00

IPO Market price

₹800.16 Cr

IPO Details

IPO Date 29 May
IPO Listing Date 29 May
IPO Face Value ₹10 Per Equity Share
IPO Price Range ₹343.00
IPO Issue Size 62,53,200 Equity Shares
IPO Sale Type Fresh capital cum OFS
Employee Discount -
IPO Issue Type Book build Issue
IPO Listing NSE SME Platform
hare Holding Pre Issue 1,70,74,999 shares

IPO Timeline

IPO Open Date 21 May
IPO Close Date 25 May
IPO Allotment (Tentative) 26 May
Refunds 27 May
Credit to Demat Account 27 May
IPO Listing Date 29 May

IPO Reservation

Category Offer
QIB Shares Offered 11,88,000 Shares
NII (HNI) Shares Offered 8,91,600 Shares
Retail Shares Offered 20,79,200 Shares

IPO Lot Size

Application Lots Share Amount
Retail (Min) 2 800 ₹2,74,400
Retail (Max) 2 800 ₹2,74,400
S-HNI (Min) 3 1,200 ₹4,11,600
S-HNI (Max) 7 2,800 ₹9,60,400
B-HNI (Min) 8 3,200 ₹10,97,600
About Company

Q-Line Biotech is a leading Indian In-Vitro Diagnostics (IVD) company established in 2008 and headquartered in Lucknow, Uttar Pradesh. The company specializes in the development, manufacturing, and distribution of diagnostic instruments, rapid testing kits, pathology equipment, biochemistry reagents, and laboratory solutions. Operating under the “Make in India” initiative, Q-Line Biotech focuses on indigenous manufacturing of products such as gold nanoparticles, magnetic beads, hematology reagents, urine strips, ELISA kits, and various biochemistry parameters for the healthcare and diagnostics sector.

The company serves a broad customer base that includes hospitals, medical colleges, diagnostic laboratories, and corporate healthcare chains across India. Q-Line Biotech has built a strong international presence by exporting its products to more than 50 countries worldwide. It follows strict quality and compliance standards and holds certifications including ISO 9001:2015 and ISO 13485:2016. With a focus on innovation, quality diagnostics, and expanding healthcare access, the company continues to strengthen its position in the medical diagnostics and pathology equipment industry.

-

Company Financials (Consolidated)

Assets 561.34 455.49 339.25
Total Income 236.5 322.58 206.45
Profit After Tax 38.69 28.13 34.44
EBITDA 64.23 71.32 37.63
NET Worth 229.16 189.95 161.81
Reserves and Surplus 212.89 188.37 160.24
Total Borrowing 243.85 164.95 96.91

Key Performance Indicator (KPI)

ROE 17.66%
ROCE 23.74%
Debt/Equity 0.87
RoNW 23.74%
PAT Margin 8.97%
EBITDA Margin 22.73%
Price to Book Value -
IPO Objective

IPO Objects of the Issue

S.No. Objects of the ipo Resources Detail IPO Amount
1 Funding capital expenditure requirements for the purchase of equipment/machineries -
2 To meet out the expenses of Working Capital Requirement ₹110.00
3 To meet out the General Corporate Purposes; -
4 Offer for Sale (OFS) -

Contact Details

Q-Line Biotech Ltd.
298-281,
Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Phone: +91 522-2435570
Email: compliance@qlinebiotech.com
Website: https://qlinebiotech.com/

Detail Registrar

Purva Sharegistry (India) Pvt.Limited.
Phone: +91-022-23018261/ 23016761
Email: support@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query

Compare:

Back To Top